Drug
Ziprasidone
Ziprasidone: highest development phase Post-Market, developed by Dr. Reddy's, Pfizer. 7 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Dr. Reddy's, Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| ziprasidone NCT00137020 | Post-Market | Schizophrenia |
| Ziprasidone NCT00483548 | Phase 3 | Bipolar Disorder |
| Ziprasidone HCL (oral) NCT01113541 | Phase 3 | Bipolar Disorder |
| Ziprasidone NCT00645515 | Phase 3 | Schizophrenia |
| Ziprasidone oral capsules NCT00257166 | Phase 3 | Bipolar Disorder |
| Ziprasidone Hydrochloride NCT01581866 | Phase 1 | Healthy |
| Ziprasidone Hydrochloride NCT01581879 | Phase 1 | Healthy |
Latest
No recent events.
Follow Ziprasidone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.